CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Pfizer Inc. v. Alembic Limited

1:11-cv-01213

Overview

Case Number 1:11-cv-01213
Filing Date 2011-12-07
Status Terminated
Termination Date 2014-06-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Alembic Pharmaceuticals Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Dawn Kurtz Crompton

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

ADDRESS EXPIRED / UNKNOWN

Alembic Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Michael R. Dzwonczyk

Email: mdzwonczyk@sughrue.com

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Dawn Kurtz Crompton

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

ADDRESS EXPIRED / UNKNOWN

Plaintiff

Northwestern University NPE (University / Research)

Represented By

3 Attorneys Listed

Kevin M. Flowers

Email: kflowers@marshallip.com

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

C P Pharmaceuticals International CV Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Warner-Lambert Company LLC Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Pfizer Inc. Operating Company

Represented By

9 Attorneys Listed

Ryan P. Johnson

Email: ryan.johnson@fenwick.com

Robert E. Counihan

Email: rcounihan@fenwick.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jeffrey J. Oelke

Email: joelke@fenwick.com

Jayashree Mitra

Email: jmitra@ny.whitecase.com

Dimitrios T. Drivas

Email: ddrivas@whitecase.com

Augusta Wilson

UNDELIVERABLE EMAIL 6/20/13

Adam Gahtan

Email: agahtan@fenwick.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 16 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (16): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6197819
Gamma amino butyric acid analogs and optical isomers
Filed: 1995-04-11
Issued: 2001-03-06
Expired (Term Ended) +1359d PTA
Expires: 2018-12-30

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1359 days) / Cellect Scrutiny — Over 1359 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re 9 STIPULATION TO EXTEND TIME for Alembic Limited and Alembic Pharmaceuticals Limited to respond to the Complaint to March 5, 2012 filed by Alembi...
Entry #— • 2012-01-06
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Alembic Limited and Alembic Pharmaceuticals Limited to respond to the Complaint to March 5, 2012 - filed by Alembic Limited, Alem...
Entry #9 • 2012-01-05 Document →

Docket Entries

(34 total)
Pleading / Complaint

COMPLAINT filed against Alembic Limited, Alembic Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-987278.) - filed by Warner-Lambert Company LLC, Pfizer Inc., C P Pharmaceuticals International CV, Northwestern University. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 12/08/2011)

Entry #1 • 2011-12-07
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dmp, ) (Entered: 12/08/2011)

Entry #2 • 2011-12-07
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/27/2011. Date of Expiration of Patent: 12/30/2018.Thirty Month Stay Deadline: 4/27/2014. (dmp, ) (Entered: 12/08/2011)

Entry #3 • 2011-12-07
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,197,819 B1;. (dmp, ) (Entered: 12/08/2011)

Entry #4 • 2011-12-07
1

Disclosure Statement pursuant to Rule 7.1 filed by C P Pharmaceuticals International CV, Pfizer Inc., Warner-Lambert Company LLC identifying Corporate Parent Pfizer Inc. for C P Pharmaceuticals International CV, Warner-Lambert Company LLC. (dmp, ) (Entered: 12/08/2011)

Entry #5 • 2011-12-07
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc